Chronic Myeloid Leukaemia
Showing 1 - 12 of 12
Outcomes in Chronic Myeloid Leukaemia
Completed
- Chronic Myeloid Leukaemia
-
York, United KingdomHaematological Malignancy Research Network
Jun 7, 2023
Condition Vasoregulation Function Endothelium in CML Getting TKI
Recruiting
- Chronic Myeloid Leukaemia
- taking blood for the study of biochemical parameters and the study of microcirculation using the method of laser Doppler flowmetry
-
Moscow, Russian Federation
- +1 more
Jan 11, 2023
Imatinib-resistant/Intolerant Chronic Myeloid Leukemia Treated
Completed
- Chronic Myeloid Leukaemia
-
Rionero in Vulture, Potenza, Italy
- +32 more
Oct 24, 2022
BCR-ABL+ Chronic Myeloid Leukaemia in Chronic Phase
Active, not recruiting
- Chronic Phase Philadelphia Positive
- +2 more
-
Alessandria, Italy
- +55 more
Jan 4, 2022
Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma, Acute Myeloid Leukaemia Trial in United Kingdom (Reduced intensity haplodentical
Active, not recruiting
- Hodgkin's Lymphoma
- +8 more
- Reduced intensity haplodentical stem cell transplant
- Myeloablative haploidentical stem cell transplant
-
Birmingham, United Kingdom
- +11 more
Sep 27, 2021
Describe The Real World Use Of Bosutinib In The UK And
Completed
- Chronic Myeloid Leukaemia
-
Liverpool, Merseyside, United Kingdom
- +2 more
May 1, 2019
Acute Myeloid Leukaemia, Chronic Myeloid Leukaemia Trial in Bristol, London (WT1 TCR-transduced T cells)
Completed
- Acute Myeloid Leukaemia
- Chronic Myeloid Leukaemia
- WT1 TCR-transduced T cells
-
Bristol, United Kingdom
- +1 more
Oct 1, 2018
Chronic Myeloid Leukaemia Trial in France (Imatinib stop)
Completed
- Chronic Myeloid Leukaemia
- Imatinib stop
-
Angers, France
- +31 more
Mar 12, 2018
Chronic Myeloid Leukaemia Trial in Liverpool (Imatinib, nilotinib, dasatinib)
Unknown status
- Chronic Myeloid Leukaemia
- Imatinib
- +2 more
-
Liverpool, United KingdomUniversity of Liveprool
May 3, 2017
Chronic Myeloid Leukaemia Trial in Adelaide (Nilotinib, Pegylated interferon alpha-2b, Imatinib)
Unknown status
- Chronic Myeloid Leukaemia
- Nilotinib, Pegylated interferon alpha-2b, Imatinib
-
Adelaide, South Australia, AustraliaRoyal Adelaide Hospital
May 18, 2014